TY - JOUR
T1 - Sex and Gender Differences in Migraine - Evaluating Knowledge Gaps
AU - Schroeder, Rachel A.
AU - Brandes, Jan
AU - Buse, Dawn C.
AU - Calhoun, Anne
AU - Eikermann-Haerter, Katharina
AU - Golden, Katie
AU - Halker, Rashmi
AU - Kempner, Joanna
AU - Maleki, Nasim
AU - Moriarty, Maureen
AU - Pavlovic, Jelena
AU - Shapiro, Robert E.
AU - Starling, Amaal
AU - Young, William B.
AU - Nebel, Rebecca A.
N1 - Funding Information:
This work was supported by programmatic grants from Amgen, Eli Lilly & Company, Novartis, and the Allergan Foundation.
Funding Information:
Ms. Schroeder, Dr. Eikermann-Haerter, Dr. Maleki, and Dr. Nebel have nothing to disclose. Dr. Brandes has received grant support from Allergan, Amgen, Clinivest, Teva, Co-Lucid, Zozano, and Arteus; received consulting fees from Amgen, Supernus, and Promius; and served on the speaker’s bureau for Amgen, Supernus, Promius, Depomed, Pernix, Teva, Avanir. She is also on the advisory boards of Amgen, Avanir, Supernus, Teva, Lilly, and Promius. Dr. Buse has received grant support and honoraria from Allergan, Amgen, Avanir, Biohaven, Eli Lilly & Company, Promeius, and Teva. She is on the editorial boards of Current Pain and Headache Reports, The Journal of Headache and Pain, Pain Medicine News, and Pain Pathways magazine. Dr. Calhoun has served as a consultant for Alder, Amgen, Avanir, De-pomed, electroCore, Eli Lilly & Company, and Teva, and served on the speaker’s bureau for Alder, Amgen, Avanir, Depomed, electroCore, Supernus, and Teva. Ms. Golden has received honoraria from Teva. Dr. Halker has served on the advisory board for Amgen. Dr. Moriarty had served on the advisory boards of Allergan and Amgen. Dr. Kempner has received honoraria from Amgen. Dr. Pavlovic has served on the advisory board for Alder and received consulting honoraria from Allergan and Promeus Pharma. Dr. Shapiro has received consulting fees from Eli Lilly & Company. Dr. Starling has received consulting fees from Amgen and Eli Lilly & Company; served on the advisory boards of Alder, Amgen, Eli Lilly & Company, and eNeura; and received speaking honoraria from eNeura and Medscape. In the past 24 months, Dr. Young has served on the advisory boards of Alder, Allergan, Avanir, and Supernus; received consulting fees from Alder, Allergan, and Supernus; and served on the speaker’s bureau for Amgen. He has received research support from Alder, Allergan, Amgen, Autonomic Technologies, Colucid, Cumberland, Dr. Reddy Laboratories, Eli Lilly & Company, Merz, Novartis, PCORI, Scion, Teva, and Zosano.
Publisher Copyright:
© Copyright 2018, Mary Ann Liebert, Inc. 2018.
PY - 2018/8
Y1 - 2018/8
N2 - Migraine is a common chronic neurological disease that disproportionately affects women. Migraine has significant negative effects on physical, emotional, and social aspects of health, and can be costly for patients, employers, and society as a whole. Growing evidence supports the roles of sex and gender in migraine risk, pathophysiology, presentation, diagnosis, treatment, and management. However, sex and gender differences in migraine have received limited attention, which can impede advancements in migraine detection, treatment, care, and education. The Society for Women's Health Research convened an interdisciplinary expert panel of researchers, clinicians, and advocates for a roundtable meeting to review the current research on sex and gender differences in migraine. This review summarizes discussions from the roundtable and prioritizes areas of need that warrant further attention in migraine research, care, and education. Examining sex and gender differences in migraine and addressing knowledge gaps will decrease the health and economic burden of migraine for both women and men.
AB - Migraine is a common chronic neurological disease that disproportionately affects women. Migraine has significant negative effects on physical, emotional, and social aspects of health, and can be costly for patients, employers, and society as a whole. Growing evidence supports the roles of sex and gender in migraine risk, pathophysiology, presentation, diagnosis, treatment, and management. However, sex and gender differences in migraine have received limited attention, which can impede advancements in migraine detection, treatment, care, and education. The Society for Women's Health Research convened an interdisciplinary expert panel of researchers, clinicians, and advocates for a roundtable meeting to review the current research on sex and gender differences in migraine. This review summarizes discussions from the roundtable and prioritizes areas of need that warrant further attention in migraine research, care, and education. Examining sex and gender differences in migraine and addressing knowledge gaps will decrease the health and economic burden of migraine for both women and men.
KW - gender
KW - headache
KW - migraine
KW - pain
KW - sex
UR - http://www.scopus.com/inward/record.url?scp=85052194629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052194629&partnerID=8YFLogxK
U2 - 10.1089/jwh.2018.7274
DO - 10.1089/jwh.2018.7274
M3 - Review article
C2 - 30129895
AN - SCOPUS:85052194629
VL - 27
SP - 965
EP - 973
JO - Journal of women's health (2002)
JF - Journal of women's health (2002)
SN - 1540-9996
IS - 8
ER -